Shots: The company resubmits the sBLA to the FDA for updating the dosing frequency for Keytruda, to include a 400mg dose infused over 30mis q6w, in addition to the currently […]readmore
Tags : Six-Week
Shots: The US FDA has accepted six sBLA for review to update dosing frequency of Keytruda (400 mg q6w) infused over 30mins. for multiple indications including melanoma, classical Hodgkin lymphoma, […]readmore